NDC product
Vir Combination
NDC 43742-2123 · Deseret Biologicals, Inc.
Key facts
| Product NDC | 43742-2123 |
|---|---|
| Proprietary name | Vir Combination |
| Nonproprietary name | Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 DNA, Herpes Simplex Virus 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Influenzinum (2022-2023) |
| Substances | HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN, HUMAN HERPESVIRUS 5, HUMAN HERPESVIRUS 1, HUMAN HERPESVIRUS 2, HUMAN HERPESVIRUS 4, HEPATITIS B VIRUS, HUMAN HERPESVIRUS 6, INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED) |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | Deseret Biologicals, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Actively Acquired Immunity [PE], Live Human Adenovirus Type 4 Vaccine [EPC], Vaccines, Adenovirus [Chemical/Ingredient], Live, Unattenuated [Chemical/Ingredient] |
| Marketing start | Jan 25, 2024 |
| Marketing end | Mar 20, 2029 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory